Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Stockholders Equity Over TimeStrong
Percentile Rank93
3Y CAGR+11.8%
5Y CAGR+1.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+11.8%/yr
vs +1.7%/yr prior
5Y CAGR
+1.3%/yr
Recent acceleration
Acceleration
+10.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $698.58M | -1.7% |
| 2024 | $710.40M | +21.5% |
| 2023 | $584.61M | +17.0% |
| 2022 | $499.64M | -19.6% |
| 2021 | $621.66M | -5.3% |
| 2020 | $656.50M | +119.6% |
| 2019 | $298.97M | -35.9% |
| 2018 | $466.19M | +220.4% |
| 2017 | $145.48M | -12.8% |
| 2016 | $166.92M | - |